Abstracts Archive - Page 1204 of 2607 - ACR Meeting Abstracts

Abstract Number: 263 • 2018 ACR/ARHP Annual Meeting
Racial Disparities in Total Knee Replacement Failure Are Not Explained By Poverty
Anne R. Bass¹, Jackie Szymonifka², Lisa A. Mandl¹, Bella Y. Mehta³, Emily Ying Lai², Stephen Lyman¹, Michael L. Parks¹, Serene Z. Mirza², Shirin A. Dey² and Susan M. Goodman², ¹Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, ²Hospital for Special Surgery, New York, NY, ³Hospital for Special Surgery/Weill Cornell Medicine/Mailman School of Public Health, New York, NY
Background/Purpose: U.S. blacks have a higher risk of revision total knee replacement (TKR) than whites, but whether this is mediated by poverty is unknown. The…
Abstract Number: 264 • 2018 ACR/ARHP Annual Meeting
Relationships between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus
Kimberly DeQuattro¹, Laura Trupin¹, Jing Li¹, Patricia Katz², Cristina Lanata¹, Edward H. Yelin³, Stephanie Rush³, Lindsey A. Criswell², Louise Murphy⁴, Maria Dall'Era⁵ and Jinoos Yazdany¹, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²University of California San Francisco, San Francisco, CA, ³Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ⁴Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ⁵University of California, San Francisco, San Francisco, CA
Background/Purpose: Adverse childhood experiences (ACEs) such as abuse, neglect and domestic violence are associated with poor adult health status and immune dysregulation. The extent and…
Abstract Number: 265 • 2018 ACR/ARHP Annual Meeting
Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry
S. Sam Lim¹, Cristina Drenkard¹, Gaobin Bao¹, Jayanti Mukherjee², Sean E. Connolly², Andrew Napoli², Damemarie Paul² and Evo Alemao², ¹Emory University, Atlanta, GA, ²Bristol-Myers Squibb, Princeton, NJ
Background/Purpose: There is a lack of population-based statistics on utilization and costs of direct healthcare of systemic lupus erythematosus (SLE) in the US, which disproportionately…
Abstract Number: 266 • 2018 ACR/ARHP Annual Meeting
Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus
Lisa Gaynon¹, Nancy Liu², Laura Trupin³, Jing Li⁴, Ishita Aggarwal³, Patricia Katz³, Maria Dall'Era⁵, Lindsey A. Criswell³, Cristina Lanata⁶, Louise Murphy⁷ and Jinoos Yazdany⁵, ¹Internal Medicine, California Pacific Medical Center, San Francisco, CA, ²Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, ³University of California San Francisco, San Francisco, CA, ⁴Medicine, UC San Francisco, San Francisco, CA, ⁵University of California, San Francisco, San Francisco, CA, ⁶Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁷Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose: Systemic lupus erythematosus (SLE) presents heterogeneously and can be difficult to diagnose. Once diagnosed, prompt evaluation and treatment by a specialist can prevent morbidity.…
Abstract Number: 267 • 2018 ACR/ARHP Annual Meeting
Patterns of Access to Prescription Medications Among Lupus Cases and Controls in the Population-Based Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
Deeba Minhas¹, Wendy Marder¹, Siobán Harlow², Suzanna Zick³, Afton L. Hassett⁴, Kamil E. Barbour⁵, Charles G. Helmick⁵, Caroline Gordon⁶, Jiha Lee¹, Amrita Padda¹, W. Joseph McCune¹ and Emily C. Somers¹, ¹Rheumatology, University of Michigan, Ann Arbor, MI, ²Epidemiology Department- School of Public Health, Obstetrics and Gynecology- Medical School, University of Michigan, Ann Arbor, MI, ³Department of Family Medicine, University of Michigan, Ann Arbor, MI, ⁴Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ⁶University of Birmingham, Birmingham, United Kingdom
Background/Purpose: Medication access and adherence are important issues in determining patient outcomes. We investigated sociodemographic factors and disparities associated with prescription medication access in a…
Abstract Number: 268 • 2018 ACR/ARHP Annual Meeting
The Effect of Renaming Gout to Urate Crystal Arthritis on Illness and Treatment Perceptions in Māori (the Indigenous People of Aotearoa/New Zealand)
Nicola Dalbeth¹, Meihana Douglas¹, Kate MacKrill¹, Leanne Te Karu², Maria Kleinstäuber¹ and Keith Petrie¹, ¹University of Auckland, Auckland, New Zealand, ²Ngā Kaitiaki o Te Puna Rongoā o Aotearoa, Taupō, New Zealand
Background/Purpose: Recent research has suggested that renaming gout to a pathophysiological illness label (urate crystal arthritis) avoids inaccurate lay perceptions of gout and promotes…
Abstract Number: 269 • 2018 ACR/ARHP Annual Meeting
Adverse Event Reporting Rates and Placebo/Standard-of-Care-Arm American College of Rheumatology Responses Vary By Region in Rheumatoid Arthritis Trials
Katie Tuckwell, Edmond Teng, Jenny Chia, Daisy Lee, Joshua Galanter, Jodie Peake and Daniel Keebler, Genentech, Inc., South San Francisco, CA
Background/Purpose: Clinical trials are becoming increasingly globalized, with more representation from Asia, Latin America, and the Russian Federation and Eastern Europe (RFEE).1 Adverse event (AE)…
Abstract Number: 270 • 2018 ACR/ARHP Annual Meeting
Gaps in Knowledge about the Ontario Trillium Drug Program
Ambika Gupta¹, Heather Khey Beldman², Caroline Averns³ and Henry Averns³, ¹Internal Medicine, Queen's University, Kingston, ON, Canada, ²Department of Family Medicine, Queen's University, Kingston, ON, Canada, ³Private Practice, Kingston, ON, Canada
Background/Purpose: Medication costs for patients with a rheumatic disease can add up as they may be on numerous and/or costly medications including anti-inflammatory medications, disease-modifying…
Abstract Number: 271 • 2018 ACR/ARHP Annual Meeting
Health Care Disparities for Infectious and Non-Infectious Uveitis in the US
Krati Chauhan¹, Steven Scaife² and James T. Rosenbaum³, ¹Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL, ²Center for clinical research, Southern Illinois University- School of Medicine, Springfield, IL, ³Ophthalmology, Oregon Health & Science University and Legacy Devers Eye Institute, Portland, OR
Background/Purpose: Autoimmune disease like systemic lupus erythematous and rheumatoid arthritis are influenced by health care disparities due to race, income, sex and age. Uveitis is…
Abstract Number: 272 • 2018 ACR/ARHP Annual Meeting
Ethnic Disparities in Lupus Nephritis Outcomes in the Inland Empire: Findings from the Southern California Lupus Registry
Kristal Choi¹, Arezoo Haghshenas², Abigail Benitez³, Lorena Salto¹, Karina Torralba⁴ and Vaneet K. Sandhu², ¹Loma Linda University, Loma Linda, CA, ²Division of Rheumatology, Loma Linda University, Loma Linda, CA, ³Rheumatology, Loma Linda University, Loma Linda, CA, ⁴Loma Linda University Medical Center, Loma Linda, CA
Background/Purpose: Loma Linda University Health (LLUH) serves Riverside and San Bernardino County, which are the two largest counties by geographic size in California and make…
Abstract Number: 273 • 2018 ACR/ARHP Annual Meeting
Incidence of Systemic Lupus Erythematosus By Income: A Nationwide Study
Ali Duarte-Garcia¹, Cynthia S. Crowson², Rozalina McCoy¹, Stephanie Schilz³, Holly Van Houten⁴, Lindsey Sangaralingham⁴, Vaidehi R. Chowdhary⁵, Shreyasee Amin⁶, Kenneth J. Warrington⁷, Eric L. Matteson⁸ and Nilay Shah⁹, ¹Mayo Clinic College of Medicine and Science, Rochester, MN, ²Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, ³Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, ⁵Internal Medicine, Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁶Rheumatology, Mayo Clinic, Rochester, MN, ⁷Rheumatology, Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, ⁸Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, ⁹Health Care Policy and Research, Mayo Clinic College of Medicine and Science, Rochester, MN
Background/Purpose: The incidence of systemic lupus erythematosus (SLE) varies significantly across patients from different racial/ethnic backgrounds, and is highest in non-Caucasian populations. In addition, poverty…
Abstract Number: 274 • 2018 ACR/ARHP Annual Meeting
Socioeconomic Disparities in Disease Activity in Patients with Rheumatoid Arthritis
Lei Zhu¹, Evelyn Talbott² and Larry W. Moreland¹, ¹Division of Rheumatology and Clinical Immunology, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ²Epidemiology, University of Pittsbugh, Pittsburgh, PA
Background/Purpose: To develop a methodology for well-defined rheumatoid arthritis (RA) measurement as an outcome and provide a clear definition of social determinants related to disease…
Abstract Number: 275 • 2018 ACR/ARHP Annual Meeting
Health Equity: Access to Rituximab for Patients Comparing Variable Access in a Single Rheumatology Clinic
Raymond Chu¹, Catherine Mallon¹, Jan Willem Cohen Tervaert¹ and Elaine Yacyshyn², ¹University of Alberta, Edmonton, AB, Canada, ²Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The purpose of our study is to investigate the difference in time to access of rituximab therapy between patients with rheumatoid arthritis (RA) compared…
Abstract Number: 276 • 2018 ACR/ARHP Annual Meeting
Gender Differences in TNFi Treatment Adherence and Response in As Patients: A Prospective Longitudinal Cohort Study
S. Hoekstra¹, Tamara Rusman², Michael T. Nurmohamed³, Christiaan van Denderen⁴ and Irene van der Horst-Bruinsma⁵, ¹Rheumatology, VU Univeresity Medical Center, Amsterdam, Netherlands, ²Rheumatology, VU University medical centre, Amsterdam, Netherlands, ³Rheumatology, Amsterdam Rheumatology and immunology Center, VU University Medical Center, Amsterdam, Netherlands, ⁴Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, ⁵Rheumatology, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: Despite several observations of gender differences in TNF inhibitor (TNFi) treatment response and adherence in ankylosing spondylitis (AS) patients, limited studies were conducted. Our…
Abstract Number: 277 • 2018 ACR/ARHP Annual Meeting
Outcomes of Telemedicine for Rheumatoid Arthritis in the Alaska Native Population
Elizabeth Ferucci¹, Tammy Choromanski¹, Gretchen Day² and Sarah Freeman³, ¹Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ²Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, ³Telehealth, Alaska Native Tribal Health Consortium, Anchorage, AK
Background/Purpose: In rheumatoid arthritis (RA), access to a rheumatologist is associated with improved quality of care and outcomes. Telemedicine has been proposed as a solution…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].